Advanced Bionics Inc., the Valencia-based medical technology company, said Wednesday it has voluntarily stopped distributing its cochlear ear implants after a federal public health notification, released in July, warned that recipients may be at greater risk of contracting bacterial meningitis.
Douglas Lynch, director of corporate marketing for Advanced Bionics, said the company is also recommending that users of its ear implants, which are used to treat people with severe to profound deafness, receive a meningitis vaccination.
“We are strongly recommending that cochlear users contact their physician or pediatrician to get a meningitis vaccination,” said Lynch, himself a cochlear ear implant user. “If anyone using our device has any out-of-pocket costs related to a meningitis vaccination, Advanced Bionics will reimburse them.”
In July, the Food and Drug Administration reported that at least 25 cases of meningitis have been diagnosed worldwide in children and adults who have undergone cochlear implantation. Nine of those implantation recipients have died from the disease.
Cochlear ear implants are manufactured and distributed throughout the world by Advanced Bionics, Australia’s Cochlear and Med El Medical Electronics in North Carolina.
“At least half of the reported cases have been with our technology,” Lynch said. “More than half of the deaths have come from our technology.
“There have been 10,000 implantations of our device worldwide, and of those 10,000, approximately 500 contracted meningitis before implantation and there are 25 cases where they contracted the disease after implantation,” he said. “Even so, our responsibility is to ensure the safety of our device.”
Bacterial meningitis, treatable with antibiotics, is an infection of the fluid in the spinal cord and the fluid that surrounds the brain, which may result in brain damage, hearing loss or learning disability, according to the Center for Disease Control and Prevention.
High fever, headache, stiff neck, nausea, vomiting, discomfort when looking into bright lights, confusion, and sleepiness are symptoms of meningitis in persons over the age of 2. In infants, symptoms — which may be absent or difficult to detect — include fever, headache and neck stiffness, according to the CDC.
Lynch said Advanced Bionics first became aware of the meningitis cases in the spring.
“We reported those cases to the FDA and launched an investigation to see if there was an increased risk of cochlear users contracting meningitis,” Lynch said. “We are a responsible company.”
Cochlear implants are devices containing electrodes that are positioned in the inner ear to activate auditory nerve fibers, allowing for transmission of sound signals to the brain.
Lynch said Advanced Bionics’ hypothesis is that the electrode positioner, one of two components surgically implanted in the ear with the cochlear, may be leading to the possible increased risk of contracting meningitis.
“When we heard about this, we made a hypothesis that this part maybe the part,” Lynch said. “Our investigation is ongoing.”
He said Advanced Bionics has sent letters to all recipients of its implant and asked them if they have or think they have contracted meningitis.
“We are doing all we can to ensure that people who use or are thinking of using our device are vaccinated against meningitis,” Lynch said. “The vaccinations have been shown to be highly effective.”
Advanced Bionics is seeking FDA approval of a cochlear ear implant that does not include the electrode positioner.
To report cases of meningitis in cochlear implant recipients call the FDA at (800) 332-1088.
